CSF and plasma GABA levels in Parkinson's disease
- PMID: 7086446
- PMCID: PMC491347
- DOI: 10.1136/jnnp.45.3.253
CSF and plasma GABA levels in Parkinson's disease
Abstract
CSF gamma-aminobutyric acid (GABA) levels were reduced in patients with idiopathic Parkinson's disease when compared with age matched controls, but the difference was not significant. However, when the Parkinsonian patients were subdivided, CSF GABA levels were lower in the levodopa treated group than in the untreated group and the controls. There was no difference in plasma GABA levels between Parkinsonian patients and controls.
Similar articles
-
Low CSF gamma-aminobutyric acid levels in Parkinson's Disease. Effect of levodopa and carbidopa.Arch Neurol. 1982 Jul;39(7):391-2. doi: 10.1001/archneur.1982.00510190009002. Arch Neurol. 1982. PMID: 7103767
-
CSF GABA levels in Parkinson's disease.Adv Neurol. 1984;40:427-30. Adv Neurol. 1984. PMID: 6695622
-
Treatment of Parkinson's disease with sodium valproate: clinical, pharmacological, and biochemical observations.Can J Neurol Sci. 1979 Aug;6(3):337-43. doi: 10.1017/s0317167100023970. Can J Neurol Sci. 1979. PMID: 385131 Clinical Trial.
-
Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.Mov Disord. 1987;2(2):117-23. doi: 10.1002/mds.870020206. Mov Disord. 1987. PMID: 2973560
-
Low CSF GABA in Parkinsonian patients who respond poorly to therapy or suffer from the "on-off" phenomenon.Ann Neurol. 1982 Jan;11(1):76-9. doi: 10.1002/ana.410110113. Ann Neurol. 1982. PMID: 6120678 No abstract available.
Cited by
-
Change in plasma levels of amino acid neurotransmitters and its correlation with clinical heterogeneity in early Parkinson's disease patients.CNS Neurosci Ther. 2013 Nov;19(11):889-96. doi: 10.1111/cns.12165. Epub 2013 Aug 24. CNS Neurosci Ther. 2013. PMID: 23981689 Free PMC article.
-
Metabolomic Analysis Provides Insights on Paraquat-Induced Parkinson-Like Symptoms in Drosophila melanogaster.Mol Neurobiol. 2016 Jan;53(1):254-269. doi: 10.1007/s12035-014-9003-3. Epub 2014 Nov 27. Mol Neurobiol. 2016. PMID: 25428622
-
Comparison of Half-Effective Concentration of Propofol in Patients with Parkinson's Disease and Non-Parkinson's Disease.Clin Interv Aging. 2023 Feb 28;18:307-315. doi: 10.2147/CIA.S380416. eCollection 2023. Clin Interv Aging. 2023. PMID: 36879829 Free PMC article.
-
Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.Front Cell Neurosci. 2014 Nov 11;8:369. doi: 10.3389/fncel.2014.00369. eCollection 2014. Front Cell Neurosci. 2014. PMID: 25426023 Free PMC article. Review.
-
Plasma and cerebrospinal fluid gamma-aminobutyric acid in neurological disorders.J Neurol Neurosurg Psychiatry. 1982 Oct;45(10):931-5. doi: 10.1136/jnnp.45.10.931. J Neurol Neurosurg Psychiatry. 1982. PMID: 7143013 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical